Similar articles

• Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.

  Szekeres L, Udvary E, Papp JG. Szekeres L, et al. Acta Biol Med Ger. 1972;28(6):1031-9. Acta Biol Med Ger. 1972. PMID: 4404698 No abstract available.
• Cardiac effects of isoproterenol during graded myocardial ischemia.

  Lekven J, Kjekshus JK, Mjös OD. Lekven J, et al. Scand J Clin Lab Invest. 1974 Apr;33(2):161-71. Scand J Clin Lab Invest. 1974. PMID: 4850884 No abstract available.
• [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].

  Suzuki K, Kubota M, Odashiro M, Yasuda K, Goto Y. Suzuki K, et al. Masui. 1972 Jan;21(1):46-50. Masui. 1972. PMID: 4401935 Japanese. No abstract available.
• Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.

  Gibson DG. Gibson DG. Drugs. 1974;7(1):8-38. doi: 10.2165/00003495-197407010-00002. Drugs. 1974. PMID: 4151693 Review. No abstract available.
• [Beta adrenergic drugs in arterial hypertension].

  Gysling E. Gysling E. Union Med Can. 1972 Jul;101(7):1336-41. Union Med Can. 1972. PMID: 4402882 Review. French. No abstract available.